JP2017535292A5 - - Google Patents

Download PDF

Info

Publication number
JP2017535292A5
JP2017535292A5 JP2017545528A JP2017545528A JP2017535292A5 JP 2017535292 A5 JP2017535292 A5 JP 2017535292A5 JP 2017545528 A JP2017545528 A JP 2017545528A JP 2017545528 A JP2017545528 A JP 2017545528A JP 2017535292 A5 JP2017535292 A5 JP 2017535292A5
Authority
JP
Japan
Prior art keywords
modified
cells
cell
tumor
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017545528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017535292A (ja
JP7146397B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/061189 external-priority patent/WO2016081518A2/en
Publication of JP2017535292A publication Critical patent/JP2017535292A/ja
Publication of JP2017535292A5 publication Critical patent/JP2017535292A5/ja
Priority to JP2020214661A priority Critical patent/JP7317793B2/ja
Application granted granted Critical
Publication of JP7146397B2 publication Critical patent/JP7146397B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017545528A 2014-11-17 2015-11-17 改変γδT細胞 Active JP7146397B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020214661A JP7317793B2 (ja) 2014-11-17 2020-12-24 改変γδT細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462080500P 2014-11-17 2014-11-17
US62/080,500 2014-11-17
PCT/US2015/061189 WO2016081518A2 (en) 2014-11-17 2015-11-17 Engineered gamma delta t-cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020214661A Division JP7317793B2 (ja) 2014-11-17 2020-12-24 改変γδT細胞

Publications (3)

Publication Number Publication Date
JP2017535292A JP2017535292A (ja) 2017-11-30
JP2017535292A5 true JP2017535292A5 (enExample) 2019-01-10
JP7146397B2 JP7146397B2 (ja) 2022-10-04

Family

ID=56014675

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017545528A Active JP7146397B2 (ja) 2014-11-17 2015-11-17 改変γδT細胞
JP2020214661A Active JP7317793B2 (ja) 2014-11-17 2020-12-24 改変γδT細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020214661A Active JP7317793B2 (ja) 2014-11-17 2020-12-24 改変γδT細胞

Country Status (14)

Country Link
US (2) US11135245B2 (enExample)
EP (2) EP4545639A3 (enExample)
JP (2) JP7146397B2 (enExample)
KR (1) KR102660362B1 (enExample)
CN (2) CN117143814A (enExample)
AU (2) AU2015350103A1 (enExample)
CA (1) CA2966634C (enExample)
DK (1) DK3220926T3 (enExample)
ES (1) ES3023783T3 (enExample)
IL (2) IL297773B2 (enExample)
MX (1) MX2017006408A (enExample)
RU (1) RU2756247C2 (enExample)
WO (1) WO2016081518A2 (enExample)
ZA (1) ZA201703505B (enExample)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1814580T (pt) 2004-11-24 2016-11-11 Hutchinson Fred Cancer Res Métodos de utilização de il-21 para imunoterapia adotiva e identificação de antigénios tumorais
GB201506423D0 (en) 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
IL297773B2 (en) 2014-11-17 2024-07-01 Adicet Bio Inc Engineered gamma delta t-cells
JP6743051B2 (ja) 2015-01-27 2020-08-19 ラヴァ・セラピューティクス・ベー・フェー Cd1dを標的とする単一ドメイン抗体
GB201507368D0 (en) 2015-04-30 2015-06-17 Ucl Business Plc Cell
PL3307875T3 (pl) 2015-06-09 2022-08-01 Lymphact - Lymphocyte Activation Technologies, S.A. Sposoby wytwarzania limfocytów t tcr gamma delta+
US12005078B2 (en) 2015-09-03 2024-06-11 The Uab Research Foundation Genetically engineered drug resistant T cells and methods of using the same
AU2017261804A1 (en) 2016-05-12 2018-11-29 Adicet Therapeutics, Inc. Methods for selective expansion of γδ T-cell populations and compositions thereof
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10426796B2 (en) * 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
WO2018027036A1 (en) 2016-08-03 2018-02-08 Dipersio John F Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
KR102032354B1 (ko) 2016-11-11 2019-10-16 가톨릭대학교 산학협력단 신규한 배양보조세포 및 이를 이용한 감마 델타 t 세포의 증식 방법
EP3544996A2 (en) 2016-11-22 2019-10-02 TCR2 Therapeutics Inc. Compositions and methods for tcr reprogramming using fusion proteins
AU2017382902A1 (en) * 2016-12-21 2019-07-18 TCR2 Therapeutics Inc. Engineered T cells for the treatment of cancer
EP3580331B1 (en) * 2017-02-08 2022-06-01 Agency For Science, Technology And Research Gamma delta t cells and a method of augmenting the tumoricidal activity of the same
WO2018170335A1 (en) 2017-03-15 2018-09-20 Orca Biosystems Inc. Compositions and methods for hematopoietic stem cell transplants
GB201707048D0 (en) * 2017-05-03 2017-06-14 King S College London Expansion of gamma delta cells, compositions, and methods of use thereof
US12384830B2 (en) * 2017-06-02 2025-08-12 Regents Of The University Of Minnesota Compositions and methods for improving immunotherapy
WO2018236986A1 (en) * 2017-06-20 2018-12-27 The Trustees Of Columbia University In The City Of New York Engineered t-cell receptors and methods of their use
MA49512A (fr) 2017-06-28 2020-05-06 Regeneron Pharma Protéines de liaison à l'antigène anti-papillomavirus humain et leurs méthodés d'utilisation
WO2019053272A1 (en) * 2017-09-15 2019-03-21 King's College London COMPOSITIONS AND METHODS FOR IMPROVING T GAMMA DELTA LYMPHOCYTES IN INTESTINE
TWI687227B (zh) * 2017-10-03 2020-03-11 生倍科技股份有限公司 用於t細胞免疫療法之組合及其用途
CN109777778B (zh) * 2017-11-14 2023-07-18 中国科学院广州生物医药与健康研究院 一种基因改造的γδT细胞
AU2018370120C1 (en) 2017-11-15 2024-05-30 Adicet Therapeutics, Inc. Methods for selective expansion of d3 yd T-cell populations and compositions thereof
DE102017127984B4 (de) 2017-11-27 2019-12-05 Immatics US, Inc. Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
CN108129566B (zh) * 2017-12-31 2021-05-11 中国科学院武汉病毒研究所 靶向间皮素的c-型单域抗体及其制备方法与应用
EP3765054A4 (en) * 2018-01-19 2022-01-12 The Trustees Of The University Of Pennsylvania COMPOSITIONS AND METHODS FOR TARGETING GAMMA DELTA T LYMPHOCYTES USING CHIMERIC ANTIGEN RECEPTORS
US12077598B2 (en) 2018-03-16 2024-09-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. Chimeric antigen receptors with mutated CD28 phosphorylation sites
GB201804701D0 (en) 2018-03-23 2018-05-09 Gammadelta Therapeutics Ltd Lymphocytes expressing heterologous targeting constructs
JP7055469B2 (ja) * 2018-05-08 2022-04-18 国立大学法人大阪大学 ホモ接合型細胞の作製方法
CN110577932A (zh) * 2018-06-07 2019-12-17 亘喜生物科技(上海)有限公司 一种脐带血来源的嵌合抗原受体t细胞
BR112021000914A2 (pt) * 2018-07-18 2021-04-13 Amgen Inc. Receptores quiméricos para steap1 e seus métodos de uso
FI3830119T3 (fi) 2018-08-01 2026-01-23 Imcheck Therapeutics Anti-btn3a-vasta-aineita ja niiden käyttö syövän tai infektiosairauksien hoitamisessa
CN108949685B (zh) * 2018-08-02 2022-03-29 吉林大学第一医院 一种体外诱导扩增高杀伤活性γδT细胞的方法
US12156888B2 (en) 2018-08-07 2024-12-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. CAR T-cells for the treatment of bone metastatic cancer
US12569507B2 (en) * 2018-08-07 2026-03-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. CAR T-cells for the treatment of bone metastatic cancer
CN112105724A (zh) * 2018-08-09 2020-12-18 深圳华大生命科学研究院 无内源hla基因背景的抗原递呈细胞系的构建方法、抗原递呈细胞系及其用途
WO2020032179A1 (ja) * 2018-08-10 2020-02-13 国立大学法人京都大学 Cd3陽性細胞の製造方法
CN113307872B (zh) * 2018-08-11 2022-12-06 广东天科雅生物医药科技有限公司 一种工程化核酸、t细胞及其应用和产生方法
CN109161533B (zh) * 2018-08-28 2020-07-24 深圳市菲鹏生物制药股份有限公司 无血清培养组合物及其应用
CA3113409A1 (en) 2018-09-19 2020-03-26 Lava Therapeutics B.V. Dual acting cd1d immunoglobulin
KR20210070330A (ko) * 2018-10-01 2021-06-14 아디셋 바이오, 인크. 혈액 종양의 치료를 위한 조작된 및 비-조작된 γδ-T 세포에 관한 조성물 및 방법
AU2019354395A1 (en) * 2018-10-01 2021-05-06 Adicet Therapeutics, Inc. Compositions and methods regarding engineered and non-engineered γδ -T cells for treatment of solid tumors
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
EA202191107A1 (ru) 2018-10-23 2021-09-17 Ридженерон Фармасьютикалз, Инк. T-клеточные рецепторы ny-eso-1 и способы их применения
GB201818243D0 (en) 2018-11-08 2018-12-26 Gammadelta Therapeutics Ltd Methods for isolating and expanding cells
EP3890757A1 (en) 2018-12-03 2021-10-13 Adicet Bio Inc. Methods for selective in vivo expansion of gamma delta t-cell populations and compositions thereof
CN111544585B (zh) * 2019-02-11 2024-12-27 北京卡替医疗技术有限公司 一种可助推免疫细胞在体内扩增的佐剂
WO2020166729A1 (ja) * 2019-02-14 2020-08-20 学校法人獨協学園獨協医科大学 T細胞ワクチン
CA3130489A1 (en) * 2019-02-18 2020-08-27 Memorial Sloan-Kettering Cancer Center Combinations of multiple chimeric antigen receptors for immunotherapy
WO2020170260A1 (en) * 2019-02-24 2020-08-27 Gamida-Cell Ltd. Method of homing and retention of gammadelta t cells for generating cell compositions for use in therapy
WO2020182681A1 (en) * 2019-03-08 2020-09-17 Klinikum Der Universität München Ccr8 expressing lymphocytes for targeted tumor therapy
CN109758590B (zh) * 2019-03-28 2022-02-11 广东工业大学 一种用于筛选人前列腺癌肿瘤抗原表位肽的方法
PH12021552476A1 (en) * 2019-03-30 2022-07-18 Biontech Us Inc Compositions and methods for preparing t cell compositions and uses thereof
WO2020214957A1 (en) 2019-04-19 2020-10-22 Tcrcure Biopharma Corp. Anti-pd-1 antibodies and uses thereof
US12479890B2 (en) 2019-04-26 2025-11-25 The University Of North Carolina At Chapel Hill Chimeric antigen receptor constructs and their use in CAR-T cells
PE20220763A1 (es) * 2019-05-08 2022-05-16 Janssen Biotech Inc Materiales y metodos para modular la inmunidad mediada por celulas t
CN114728181B (zh) * 2019-07-17 2024-10-01 卡斯西部储备大学 用于治疗hiv感染的长期存活的t细胞
WO2021016652A1 (en) * 2019-07-29 2021-02-04 The University Of Melbourne METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS
EP4013504A1 (en) * 2019-08-16 2022-06-22 GammaDelta Therapeutics Limited Novel anti-tcr delta variable 1 antibodies
WO2021073290A1 (en) * 2019-10-17 2021-04-22 The University Of Hong Kong Methods to prepare v-t cells derived exosomes for treatment of epstein-barr virus-associated cancers
TWI883067B (zh) 2019-10-31 2025-05-11 美商英塞特公司 包含抗CD19抗體及γδ T細胞之抗腫瘤組合療法
JP2023504185A (ja) * 2019-12-03 2023-02-01 アディセット バイオ, インコーポレイテッド γδT細胞集団を多価薬剤で増殖させるための方法及びその組成物
AU2021211485A1 (en) 2020-01-24 2022-09-15 Regeneron Pharmaceuticals, Inc. Preferentially expressed antigen in melanoma (PRAME) T cell receptors and methods of use thereof
PE20230173A1 (es) * 2020-03-03 2023-02-01 Janssen Biotech Inc CELULAS T (gama-delta) Y USOS DE ESTAS
EP4143300A1 (en) 2020-04-28 2023-03-08 Lyell Immunopharma, Inc. Methods for culturing cells
US20230226181A1 (en) * 2020-06-22 2023-07-20 Nanjing Legend Biotech Co., Ltd. GENETIC ENGINEERING OF gamma delta T CELLS FOR IMMUNOTHERAPY
JP2023532807A (ja) 2020-07-08 2023-07-31 ラヴァ・セラピューティクス・エヌ・ヴイ Psma及びガンマ-デルタt細胞受容体に結合する抗体
CN116333999A (zh) * 2020-07-14 2023-06-27 广州泛恩生物科技有限公司 基于cxcl13阳性t细胞的用于杀伤肿瘤的tcr-t细胞及其制备方法和应用
WO2022170344A1 (en) * 2021-02-08 2022-08-11 Alexander Marson Regulation of butvrophilin subfamily 3 member a1 (btn3a1, cd277)
GB202105113D0 (en) * 2021-04-09 2021-05-26 Gammadelta Therapeutics Ltd Novel method
US20230117388A1 (en) * 2021-10-20 2023-04-20 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and materials for expanding tumor infiltrating gamma-delta t cells
WO2023092119A2 (en) 2021-11-22 2023-05-25 Ludwig Institute For Cancer Research Ltd Methods for predicting responsiveness to a cancer therapy
MX2024006821A (es) * 2021-12-05 2024-08-06 Adicet Therapeutics Inc Tratamiento de neoplasias malignas de celulas b.
KR20230105166A (ko) 2022-01-03 2023-07-11 주식회사 이뮤노맥스 감마-델타 t 세포의 증식 배양 방법
CN114149978B (zh) * 2022-02-09 2022-04-26 深圳博雅感知药业有限公司 制备car-t细胞的方法
IL314940A (en) 2022-02-16 2024-10-01 Priothera Sas Methods of treatment with car cells in combination with s1p receptor modulators
GB202204926D0 (en) 2022-04-04 2022-05-18 Gammadelta Therapeutics Ltd Method for expanding gammadelta T cells
WO2023242434A1 (en) * 2022-06-17 2023-12-21 Gadeta B.V. Modified immune cells
CN115624618A (zh) * 2022-09-16 2023-01-20 深圳善乐生物科技有限公司 一种HPV多肽抗原负载γδT细胞在HPV阳性宫颈癌免疫治疗中的应用
CN120322238A (zh) 2022-10-31 2025-07-15 瑞泽恩制药公司 用过继性细胞治疗与靶向的免疫细胞因子的组合来治疗癌症的方法
CN120882754A (zh) 2023-04-07 2025-10-31 瑞泽恩制药公司 用淋巴毒素β受体激动剂治疗癌症的方法
IL324813A (en) 2023-05-25 2026-01-01 Regeneron Pharma T-cell receptors that bind to peptides displaying HPV16-, MART1-, CMV-, EBV-, or influenza
US12221483B1 (en) * 2024-01-30 2025-02-11 China Medical University Hospital Fusion protein and nucleic acid encoding sequence thereof, and uses of the same
WO2025165915A1 (en) * 2024-01-31 2025-08-07 Adicet Therapeutics, Inc. Compositions and methods for enhancing engineered t cell therapies
WO2025223534A1 (en) * 2024-04-26 2025-10-30 Nanjing Legend Biotech Co., Ltd. Methods for expanding t cells
WO2025229538A1 (en) * 2024-05-01 2025-11-06 Janssen Biotech, Inc. Materials, methods, and systems for cellular expansion of gamma delta t-cells
WO2026013158A1 (en) * 2024-07-10 2026-01-15 Cytospire Therapeutics Limited Antibodies binding to constant domains of gamma delta t-cell receptors
WO2026013159A1 (en) * 2024-07-10 2026-01-15 Cytospire Therapeutics Limited Antibodies binding to constant domains of gamma delta t-cell receptors

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185250A (en) * 1986-07-03 1993-02-09 T Cell Sciences, Inc. Human γ, δT cell antigen receptor polypeptides and nucleic acids
US5260223A (en) 1986-07-03 1993-11-09 President & Fellows Of Harvard College Methods for detection of human gamma, γ T cell receptor
WO1993020221A1 (en) 1992-04-03 1993-10-14 Young Alexander T Gene therapy using targeted viral vectors
CA2110946A1 (en) * 1992-12-09 1994-06-10 Elazar Rabbani Induction of immunocompatibility by nucleic acid
AU783250B2 (en) 1999-06-17 2005-10-06 Dartmouth College Autologous adoptive immunotherapy with primed antigen-specific T cells or B cells
US6737398B1 (en) 1999-09-30 2004-05-18 National Jewish Medical And Research Center Modulation of γδ T cells to regulate airway hyperresponsiveness
AU7729000A (en) 1999-09-30 2001-04-30 National Jewish Medical And Research Center Modulation of gammadelta t cells to regulate airway hyperresponsiveness
ATE347593T1 (de) 2002-01-23 2006-12-15 Univ Utah Res Found Zielgerichtete chromosomale mutagenese mit zinkfingernukleasen
CN1306027C (zh) * 2002-12-12 2007-03-21 中国医学科学院基础医学研究所 一种体外扩增γδT淋巴细胞的方法
WO2004092741A2 (en) * 2003-04-14 2004-10-28 Montana State University Mapping discontinuous antibody or aptamer epitopes for protein structure determination and other applications
US7985739B2 (en) 2003-06-04 2011-07-26 The Board Of Trustees Of The Leland Stanford Junior University Enhanced sleeping beauty transposon system and methods for using the same
CA2569509C (en) * 2004-06-03 2014-08-12 Novimmune S.A. Anti-cd3 antibodies and methods of use thereof
US7340913B2 (en) 2004-08-05 2008-03-11 Manitowoc Foodservice Companies, Inc. Ice machine and ice-making assembly including a water distributor
WO2007143582A2 (en) 2006-06-05 2007-12-13 Baylor College Of Medicine Reversal of the suppressive function of specific t cells via toll-like receptor 8 signaling
KR101544108B1 (ko) * 2006-09-08 2015-08-13 애브비 바하마스 리미티드 인터루킨-13 결합 단백질
WO2010027797A1 (en) 2008-08-26 2010-03-11 Macrogenics Inc. T-cell receptor antibodies and methods of use thereof
NZ601247A (en) 2010-01-22 2014-10-31 Dow Agrosciences Llc Targeted genomic alteration
CA2993567C (en) * 2010-07-21 2022-06-28 Sangamo Biosciences, Inc. Methods and compositions for modification of a t-cell receptor gene
PH12013502043A1 (en) 2011-04-01 2013-12-16 Memorial Sloan Kettering Cancer Center T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2
WO2012156958A2 (en) 2011-05-19 2012-11-22 Instituto De Medicina Molecular Cell line of lymphocytes comprising gamma-delta t cells, composition and production method thereof
WO2013074916A1 (en) * 2011-11-18 2013-05-23 Board Of Regents, The University Of Texas System Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
KR101981873B1 (ko) * 2011-11-28 2019-05-23 메르크 파텐트 게엠베하 항-pd-l1 항체 및 그의 용도
CN103130894B (zh) * 2011-11-30 2017-04-12 中国医学科学院基础医学研究所 抗人γδTCR单克隆抗体的重组单链抗体G5‑4ScFv及其编码基因与应用
EP2684600A1 (en) 2012-07-10 2014-01-15 Laboratoires Meiners Sarl Core-shell capsules and methods for encapsulation of reactive ingredients by diffusional exchange through spherical capsule membranes
WO2014072446A1 (en) 2012-11-08 2014-05-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for inducing il-2-free proliferation of gamma delta t cells
CN102994448A (zh) 2012-12-13 2013-03-27 上海柯莱逊生物技术有限公司 一种体外扩增γδT细胞的方法
ES2750550T3 (es) 2013-03-01 2020-03-26 Univ Minnesota Corrección de gen a base de TALEN
KR20160068960A (ko) 2013-10-25 2016-06-15 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 면역요법을 위한 다클론성 감마 델타 t 세포
WO2015156673A1 (en) * 2014-04-10 2015-10-15 Stichting Vu-Vumc IMMUNOGLOBULINS BINDING HUMAN Vγ9Vδ2 T CELL RECEPTORS
IL297773B2 (en) 2014-11-17 2024-07-01 Adicet Bio Inc Engineered gamma delta t-cells
EP3623468A1 (en) * 2015-06-09 2020-03-18 Lymphact - Lymphocyte Activation Technologies, S.A. Methods for the production of tcr gamma delta+ t cells
JP7245647B2 (ja) 2015-07-15 2023-03-24 ジュノー セラピューティクス インコーポレイテッド 養子細胞療法用の操作された細胞
EP3743081A4 (en) 2018-01-23 2021-12-01 New York University SPECIFIC ANTIBODIES OF THE DELTA 1 CHAIN OF THE T-LYMPHOCYTE RECEPTOR

Similar Documents

Publication Publication Date Title
JP2017535292A5 (enExample)
US12371663B2 (en) Engineered γδ T-cells
TWI828625B (zh) 引導及導航控制蛋白質以及彼之製造及使用方法
JP6640726B2 (ja) キメラ抗原受容体及びその製造方法
JP2016520074A5 (enExample)
CN115003698A (zh) 抗tcr抗体分子及其用途
JP2017533706A5 (enExample)
CN107206025A (zh) 用于过继细胞治疗的方法和组合物
US20250002855A1 (en) Methods for expanding t cells for the treatment of cancer and related malignancies
WO2013175237A1 (en) Composition comprising a cd2 ligation agent and a nkg2d ligation agent
CN118891290A (zh) 细胞免疫疗法的组合物和方法
JP2021502816A5 (enExample)
Garber et al. Adoptive T-cell therapy for Leukemia
US20220280564A1 (en) Methods for expanding t cells for the treatment of cancer and related malignancies
WO2024193714A1 (zh) 细胞免疫疗法的组合物和方法
WO2025213573A1 (zh) 细胞免疫疗法的组合物和方法
WO2024240112A1 (zh) 免疫效应细胞及其应用
HK40109798A (zh) 制导和导航控制蛋白及其制备和使用方法
HK40097671A (zh) 制导和导航控制蛋白及其制备和使用方法
HK40097672A (zh) 制导和导航控制蛋白及其制备和使用方法
RU2021108422A (ru) Способы получения клеток, экспрессирующих химерный антигенный рецептор
HK1242585B (en) Engineered gamma delta t-cells
HK1242585A1 (en) Engineered gamma delta t-cells